BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23337463)

  • 1. Risk of suicide in men with low-risk prostate cancer.
    Carlsson S; Sandin F; Fall K; Lambe M; Adolfsson J; Stattin P; Bill-Axelson A
    Eur J Cancer; 2013 May; 49(7):1588-99. PubMed ID: 23337463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.
    Bill-Axelson A; Garmo H; Lambe M; Bratt O; Adolfsson J; Nyberg U; Steineck G; Stattin P
    Eur Urol; 2010 Mar; 57(3):390-5. PubMed ID: 19914773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data.
    Smith DP; Calopedos R; Bang A; Yu XQ; Egger S; Chambers S; O'Connell DL
    PLoS One; 2018; 13(6):e0198679. PubMed ID: 29897979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
    Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
    J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study.
    Fall K; Fang F; Mucci LA; Ye W; Andrén O; Johansson JE; Andersson SO; Sparén P; Klein G; Stampfer M; Adami HO; Valdimarsdóttir U
    PLoS Med; 2009 Dec; 6(12):e1000197. PubMed ID: 20016838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies.
    Guo Z; Gan S; Li Y; Gu C; Xiang S; Zhou J; Gong L; Chan FL; Wang S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):499-508. PubMed ID: 30108374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
    Fang F; Keating NL; Mucci LA; Adami HO; Stampfer MJ; Valdimarsdóttir U; Fall K
    J Natl Cancer Inst; 2010 Mar; 102(5):307-14. PubMed ID: 20124521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
    Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
    J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe Sweden.
    Bill-Axelson A; Garmo H; Nyberg U; Lambe M; Bratt O; Stattin P; Adolfsson J; Steineck G
    Eur J Cancer; 2011 Sep; 47(14):2195-201. PubMed ID: 21612913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality.
    Hugosson J; Godtman RA; Carlsson SV; Aus G; Grenabo Bergdahl A; Lodding P; Pihl CG; Stranne J; Holmberg E; Lilja H
    Scand J Urol; 2018 Feb; 52(1):27-37. PubMed ID: 29254399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicide risk among prostate cancer patients before and after the implementation of prostate-specific antigen-based prostate screening in Lithuania in 2006.
    Patasius A; Kaceniene A; Ulys A; Stukas R; Smailyte G
    Eur J Cancer Prev; 2021 Jan; 30(1):103-107. PubMed ID: 32039931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
    Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
    Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort.
    Bergengren O; Westerberg M; Holmberg L; Stattin P; Bill-Axelson A; Garmo H
    JAMA Netw Open; 2021 May; 4(5):e219444. PubMed ID: 33999165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
    Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
    Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.
    Dankner R; Boffetta P; Keinan-Boker L; Balicer RD; Berlin A; Olmer L; Murad H; Silverman B; Hoshen M; Freedman LS
    Diabetologia; 2016 Aug; 59(8):1683-91. PubMed ID: 27189066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study.
    Thorstenson A; Garmo H; Adolfsson J; Bratt O
    J Urol; 2017 Jan; 197(1):61-66. PubMed ID: 27328367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
    Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
    Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
    Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
    Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden.
    Hugosson J; Aus G; Becker C; Carlsson S; Eriksson H; Lilja H; Lodding P; Tibblin G
    BJU Int; 2000 Jun; 85(9):1078-84. PubMed ID: 10848699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.